Effect of Adiposity and Associated Local Microbial Factors on Healing and Progression of Diabetic Foot Ulcers
Prospective Exploration of the Effect of Adiposity and Associated Microbial Factors on the Healing and Progression of Diabetic Foot Ulcers in Tanzania
Sponsor: GlaxoSmithKline
This observational or N/A phase trial investigates Diabetic Foot Ulcer and is currently ongoing. GlaxoSmithKline leads this study, which shows 12 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Jan 2025 — Sep 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Dec 2021 — Feb 2023 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Dec 2019 — Nov 2020 [monthly]
Not Yet Recruiting
-
Jul 2019 — Dec 2019 [monthly]
Not Yet Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
- Muhimbili University of Health and Allied Sciences
For direct contact, visit the study record on ClinicalTrials.gov .